68Ga-PSMA-PET/CT与mpMRI在前列腺癌原发灶前列腺内肿瘤勾画中的个体内比较:101例患者回顾性分析
回顾性纳入101例活检证实原发性前列腺癌、原发治疗前3个月内接受mpMRI和68Ga-PSMA-PET的患者,比较两种影像勾画的前列腺内大体肿瘤体积(GTV)及侧别一致性。mpMRI和68Ga-PSMA-PET分别检出151和159个病灶,GTV-PET中位4.9 ml显著大于GTV-MRI中位2.8 ml(p<0.0001),PET检出更多双侧病灶(71 vs 57,p=0.03)。作者认为68Ga-PSMA-PET提供重要补充信息,按D'Amico中高危患者应在MRI基础上加做。
要点
- mpMRI与68Ga-PSMA-PET检出前列腺癌病灶数量相似(151 vs 159个)。
- GTV-PET中位4.9 ml显著大于GTV-MRI中位2.8 ml(p<0.0001),约为两倍。
- 68Ga-PSMA-PET检出双侧病灶数显著多于mpMRI(71 vs 57,p=0.03)。
核心结论
- mpMRI与68Ga-PSMA-PET检出的前列腺癌病灶数量相似,但GTV-PET体积约为GTV-MRI的两倍,且检出更多双侧病灶,68Ga-PSMA-PET提供重要补充信息。
- 作者认为按D'Amico分类的中危和高危前列腺癌患者应在MRI基础上加做68Ga-PSMA-PET以改善GTV勾画。
研究设计与样本
- 回顾性纳入101例活检证实原发性前列腺癌、原发治疗前3个月内接受mpMRI和68Ga-PSMA-PET的患者。
- 记录年龄、PSA、活检Gleason评分等临床参数,勾画MRI和PET的GTV并测量体积、判定侧别,另分析77例活检数据。
- 以侧别一致性为终点进行单因素和多因素二元逻辑回归分析。
主要发现
- mpMRI和68Ga-PSMA-PET分别检出151和159个病灶。
- GTV-MRI中位2.8 ml(95%CI 2.31-3.38 ml)显著小于GTV-PET中位4.9 ml(95%CI 3.9-6.6 ml),p<0.0001。
- 68Ga-PSMA-PET检出双侧病灶71个,显著多于mpMRI的57个(p=0.03)。
- 活检显示双侧病灶的患者中,68Ga-PSMA-PET的侧别一致性显著更高(p=0.03)。
- 单因素分析中PSA水平(p=0.02)和GTV-MRI体积(p=0.01)影响侧别一致性,多因素分析中仅GTV-MRI体积保持显著(p=0.04)。
临床怎么用
- 作者认为,按D'Amico分类的中危和高危前列腺癌患者应在MRI基础上加做68Ga-PSMA-PET以改善GTV勾画。
- 作者指出未能找到可指导何时可省略68Ga-PSMA-PET的有力证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Accurate delineation of intraprostatic gross tumor volume (GTV) is mandatory for successful fusion biopsy guidance and focal therapy planning of prostate cancer (PCa). Multiparametric magnetic resonance imaging (mpMRI) is the current gold standard for GTV delineation; however, prostate-specific membrane antigen positron emission tomography (PSMA-PET) is emerging as a promising alternative. This study compares GTV delineation between mpMRI and 68Ga-PSMA-PET in a large number of patients using validated contouring approaches. METHODS: One hundred one patients with biopsy-proven primary PCa who underwent mpMRI and 68Ga-PSMA-PET within 3 months before primary treatment were retrospectively enrolled. Clinical parameters (age, PSA, Gleason score in biopsy) were documented. GTV based on MRI and PET images were delineated; volumes measured and laterality determined. Additionally, biopsy data from 77 patients was analyzed. Univariate and multivariate binary logistic regression analyses were performed using concordance in laterality as the endpoint. RESULTS: In total mpMRI and 68Ga-PSMA-PET detected 151 and 159 lesions, respectively. Median GTV-MRI (2.8 ml, 95% CI 2.31-3.38 ml) was significantly (p < 0.0001) smaller than median GTV-PET (4.9 ml, 95% CI 3.9-6.6 ml). 68Ga-PSMA-PET detected significantly more bilateral lesions than mpMRI (71 vs 57, p = 0.03). Analysis of patients with bilateral lesions in biopsy showed a significant higher concordance of laterality in 68Ga-PSMA-PET (p = 0.03). In univariate analysis, PSA level and volume of GTV-MRI had an impact on concordance in laterality (p = 0.02 and p = 0.01), whereas in multivariate analysis, only GTV-MRI volume remained significant (p = 0.04). CONCLUSION: MpMRI and 68Ga-PSMA-PET detect a similar amount of PCa lesions. However, GTV-PET had approximately twice the volume (median 4.9 ml vs 2.8 ml) and detected significantly more bilateral lesions than mpMRI. Thus, 68Ga-PSMA-PET gives highly important complementary information. Since we could not find any strong evidence for parameters to guide when 68Ga-PSMA-PET is dispensable, it should be performed additionally to MRI in patients with intermediate and high-risk PCa according to D'Amico classification to improve GTV delineation.
引用
- Spohn S, Jaegle C, Fassbender TF, et al. Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients. Eur J Nucl Med Mol Imaging. 2020. PMID: 32342192. doi:10.1007/s00259-020-04827-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。